• Central Pattana (CPN) launched a new shopping mall, Central Park, aiming to be a new culinary landmark in Bangkok. We expect solid performance in 2H25, outpacing 1H25, supported by new projects. We remain optimistic about its earnings outlook and business plan, mainly driven by mall expansions and renovations. • Maintain BUY. Target price: Bt73.70.
Company Updates | Central Pattana (CPN TB/BUY/Bt55.50/Target: Bt73.70) CPN launched a new shopping mall, Central Park, aiming to be a new culinary landmark in Bangkok. We expect solid performance in 2H25, outpacing 1H25, supported by new projects. We remain optimistic about its earnings outlook and business plan, mainly driven mall expansions and renovations. Maintain BUY. Target price: Bt73.70.
GREATER CHINA Strategy Alpha Picks: September Conviction Calls: Add Anta, BYDE and CSCEC to our BUY list, Li Auto and OOIL to our SELL list. Take profit on Innovent, JD Logistics, Lenovo, Sino Biopharm, Tencent and TME. INDONESIA Strategy Alpha Picks: Underperformance In August: Our new Alpha Picks are ASSA, ARCI, BBCA, BBNI, BRMS, MTEL, HRUM and NCKL. MALAYSIA Strategy Alpha Picks: Wake Me Up When September Ends: Our Aug 25 Alpha Picks underperformed marginally. Sep 25 picks: Alpha IVF, Hume ...
The 2H25 outlook appears more favourable than that for 1H25, with improvements expected across all business segments, particularly in the rental & service business as well as the residential segment. We continue to favour CPN’s core business alongside its strategic project launches, while the company’s share repurchase programme should provide support to the share price. Maintain BUY. Target price: Bt79.60.
KEY HIGHLIGHTS Results Bangkok Chain Hospital (BCH TB/BUY/Bt14.10/Target: Bt17.50) 2Q25: Reported strong earnings as expected. Update Central Pattana (CPN TB/BUY/Bt54.50/Target: Bt79.60) Favourable 2H25 outlook anchored by core business resilience. Central Plaza Hotel (CENTEL TB/BUY/Bt27.00/Target: Bt33.00) Expect a gradual improvement in outlook. Charoen Pokphand Foods (CPF TB/HOLD/Bt24.40/Target: Bt24.00) 2Q25 earnings in line; 3Q25 earnings momentum to soften. The Erawan ...
GREATER CHINA Strategy Alpha Picks: August Conviction Calls: Add JBM Healthcare and Lenovo to our BUY list. Take profit on CATL, Han’s Laser, KE Holdings and Longfor. INDONESIA Strategy Alpha Picks: Underperformance In July: Our new Alpha Picks are ASSA, AKRA, ARCI, BBNI, KLBF, MTEL, and MYOR. MALAYSIA Strategy Alpha Picks: Some Opportunities Amid A “Summer Lull”: Our July 25 Alpha Picks outperformed. Aug 25 picks: Coraza, Eco World, Gamuda, Hume Cement, IJM, Inari, RHB and Zetrix. SINGAPORE ...
We expect CPN to report a net profit of approximately Bt4.2b in 2Q25 (-7% yoy, flat qoq. The rental and services business is expected to improve compared with the previous year, while hotel and residential segment performances may soften. Despite headwinds in the residential segment, we remain positive on CPN, backed by solid fundamentals and an attractive valuation. Maintain BUY. Target price: Bt79.60.
KEY HIGHLIGHTS Results Home Product Center (HMPRO TB/SELL/Bt7.30/Target: Bt5.60) 2Q25: Earnings drop yoy, in line with our forecast. Update Airports of Thailand (AOT TB/SELL/Bt42.00/Target: Bt24.00) Weaker yoy earnings expected in 3QFY25. Amata Corporation (AMATA TB/BUY/Bt15.70/Target: Bt25.00) 2Q25 results preview: Net profit momentum likely to moderate. Central Pattana (CPN TB/BUY/Bt51.75/Target: Bt79.60) Ex...
GREATER CHINA Sector Internet WAIC - Battlefield of AI applications and agents to reshape productivity. Results WuXi AppTec (2359 HK/BUY/HK$111.70/Target: HK$146.00) 1H25: Results beat; benefitting from growing CRDMO service demand. Upgrade to BUY. INDONESIA Results AKR Corporindo (AKRA IJ/BUY/Rp1,345/Target: Rp1,525) 2Q25: Momentum builds, but 4Q25 to del...
GREATER CHINA Strategy Alpha Picks: July Conviction Calls: Add CATL, KE Holdings, Longfor, Midea Group, Tencent and TME to our BUY list. Take profit on Prudential. INDONESIA Strategy Alpha Picks: Good Performances In June: Our new Alpha Picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA, AMRT and TLKM. MALAYSIA Strategy Alpha Picks: Positioning For Positive US Trade Deals: Our Jun 25 Alpha Picks outperform. Jul 25 picks: Coraza, Duopharma, Eco World, Gamuda, Hume Cement, IJM, Inari and MYEG. SINGAP...
GREATER CHINA Economics PMI Modest recovery with construction rebound. Sector Macau Gaming Jun 25 GGR beat consensus by 9%; GGR has regained momentum in recent months. INDONESIA Small/Mid Cap Highlights MAP Aktif Adiperkasa (MAPA IJ/NOT RATED/Rp700) Expanding active lifestyle retail business; 1Q25 NPAT up 21% yoy. MAL...
GREATER CHINA Strategy Alpha Picks: June Conviction Calls: Add Prudential and Sino Biopharm to our BUY list. Take profit on SHKP and Trip.com. INDONESIA Strategy Alpha Picks: Good Performances In May: Good performances from most with the exception of GOTO and BUKA. MALAYSIA Strategy Alpha Picks: Raising Emphasis On Infrastructure Plays: Our May 25 Alpha Picks outperformed with resounding success. June 25 picks: Duopharma, Eco World, Gamuda, Hume Cement, IJM, MYEG, Northeast Group. SINGAPORE S...
CPN reported a net profit of Bt4.2b in 1Q25, up 2% yoy and 9% qoq, in line with our expectation. The rental and services segment continued to deliver resilient performance, while the residential business weighed on overall earnings growth during the quarter. We remain optimistic about the core business and maintain our earnings forecasts, with a growth of 5% in 2025. Maintain BUY. Target price: Bt79.60.
KEY HIGHLIGHTS Results Central Pattana (CPN TB/BUY/Bt50.50/Target: Bt79.60) 1Q25: Earnings in line, maintain earnings forecasts. Update Banpu (BANPU TB/HOLD/Bt4.38/Target: Bt4.80) Expect 1Q25 loss to narrow qoq. PTT (PTT TB/BUY/Bt32.25/Target: Bt37.00) Subsidiary and affiliate recovery drives 1Q25 net profit higher qoq.
GREATER CHINA Strategy China And Hong Kong Property Market watch around May holiday: New-home sales recovery weakens in Apr 25; the trend of Hong Kong resident travelling north remains strong. Sector Consumer Strong Macau visitations and robust home appliance sales during Labour Day Holiday. INDONESIA Initiate Coverage Aneka Tambang (ANTM IJ/BUY/Rp2,540/Target:...
GREATER CHINA Strategy Alpha Picks: May Conviction Calls: Add Alibaba, Innovent, Shuanghuan, Trip.com to our BUY list. Take profit on JBM Healthcare and CR Land. INDONESIA Strategy Alpha Picks: Outperformance In Apr 25: Remove ICBP, EXCL and MIKA; add BBTN and GOTO. MALAYSIA Strategy Alpha Picks: Capitalising On Sentiment Turnaround: Our Apr 25 Alpha Picks underperformed. May 25 picks: Duopharma, Gamuda, IJM, IOI Properties, TIME dotCom, MYEG, Nationgate, Northeast Group and RHB Bank. SINGAPO...
GREATER CHINA Strategy Alpha Picks: May Conviction Calls Add Alibaba, Innovent, Shuanghuan, Trip.com to our BUY list. Take profit on JBM Healthcare and CR Land. Sector Aviation Airlines: 1Q25 results below expectations. Weak fuel prices to support full-year performance. Maintain UNDERWEIGHT. INDONESIA Strategy 1Q25 Results Recap ...
CPN is expected to report a net profit of Bt4.2b in 1Q25 (flat yoy, +7% qoq). We anticipate continued resilience in the rental and services business, while the residential segment is likely to see a sharp fall in transfers during 1Q25. We maintain our earnings forecast, projecting a new record high in 2025. Maintain BUY. Target price: Bt79.60.
KEY HIGHLIGHTS Update Bangkok Dusit Medical Services (BDMS TB/BUY/Bt23.50/Target: Bt33.00) Expect a healthy growth in 1Q25. Central Pattana (CPN TB/BUY/Bt48.50/Target: Bt79.60) Expect 1Q25 earnings to be stable yoy; resilient core business performance. PTT Global Chemical (PTTGC TB/BUY/Bt18.20/Target: Bt21.00) 1Q25 loss projected to decline qoq.
GREATER CHINA Initiate Coverage Tencent Music Entertainment Group (1698 HK/BUY/HK$47.80/Target: HK$60.00) World’s largest music platform with evolving social ecosystem. Results Dian Diagnostics (300244 CH/HOLD/Rmb13.99/Target: Rmb15.00) 2024: Results in line; maintain 2025 revenue growth estimate of 8.8% yoy. iFlytek (002230 CH/SELL/Rmb45.18/Target: Rmb35.00) 2024 and 1Q25: Earnings miss on heightened R&D spending; solid top-line growth. Update Sunn...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.